PMID- 35533425 OWN - NLM STAT- MEDLINE DCOM- 20220816 LR - 20220906 IS - 1879-0739 (Electronic) IS - 0271-5317 (Linking) VI - 104 DP - 2022 Aug TI - Quamoclit angulata extract supplementation attenuates hepatic damage via regulation of AMPK/SIRT associated hepatic lipid metabolism in streptozotocin and high fat diet-induced T2DM mice. PG - 10-19 LID - S0271-5317(22)00028-8 [pii] LID - 10.1016/j.nutres.2022.03.012 [doi] AB - Quamoclit angulata (QA) is a species of the Convolvulaceae family and has a regulatory effect on glucose homeostasis. However, the effects of QA on hyperglycemia-induced hepatic damage has not been elucidated. We hypothesized that QA extract (QAE) would alleviate hepatic damage through regulation of hepatic lipid accumulation in type 2 diabetes mellitus (T2DM). T2DM was induced by streptozotocin-high-fat diet in C57BL6 male mice for 8 weeks. The diabetic mice were supplemented with QAE at low dose (5 mg/kg) or high dose (HQ, 10 mg/kg) by oral gavage every day for 12 weeks. Histopathological changes in hepatic tissue were examined using hematoxylin and eosin staining, and the protein levels of biomarkers related to AMP-activation kinase (AMPK)/sirtuin-1 (SIRT1)-associated lipid metabolism were measured using Western blotting. QAE supplementation ameliorated plasma insulin and glycated hemoglobin in diabetic mice. Furthermore, QAE decreased hepatic lipid accumulation demonstrated by hepatic triglyceride and cholesterol levels. QAE supplementation induced hepatic AMPK, which activates SIRT1 accompanied by reduced lipogenesis in the HQ group. These changes were partially explained by the amelioration of advanced glycation end product, hepatic oxidative stress, inflammation, and fibrosis in diabetic mice. Altogether, QAE would be a potential nutraceutical to prevent hepatic damage by regulation of AMPK/SIRT1-associated lipid metabolism through oxidative stress, inflammation, and fibrosis in T2DM. CI - Copyright (c) 2022 Elsevier Inc. All rights reserved. FAU - Lee, Heaji AU - Lee H AD - Department of Food and Nutrition, Kyung Hee University, Seoul 02447, Korea. FAU - Kim, Younmi AU - Kim Y AD - Department of Food and Nutrition, Kyung Hee University, Seoul 02447, Korea. FAU - Kim, Sun Yeou AU - Kim SY AD - Gachon Institute of Pharmaceutical Science, Gachon University, 191 Hambakmoero, Yeonsu-gu, Incheon, 406-799, Republic of Korea. FAU - Lim, Yunsook AU - Lim Y AD - Department of Food and Nutrition, Kyung Hee University, Seoul 02447, Korea. Electronic address: ylim@khu.ac.kr. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20220327 PL - United States TA - Nutr Res JT - Nutrition research (New York, N.Y.) JID - 8303331 RN - 0 (Plant Extracts) RN - 0 (Triglycerides) RN - 5W494URQ81 (Streptozocin) RN - EC 2.7.11.31 (AMP-Activated Protein Kinases) RN - EC 3.5.1.- (Sirtuin 1) SB - IM MH - AMP-Activated Protein Kinases/metabolism MH - Animals MH - *Diabetes Mellitus, Experimental/complications/drug therapy MH - *Diabetes Mellitus, Type 2/complications/metabolism MH - Diet, High-Fat/adverse effects MH - Dietary Supplements MH - Fibrosis MH - Inflammation/metabolism MH - Lipid Metabolism MH - *Liver/metabolism/physiopathology MH - Male MH - Mice MH - Mice, Inbred C57BL MH - *Plant Extracts/pharmacology MH - Sirtuin 1/metabolism MH - Streptozocin MH - Triglycerides/metabolism OTO - NOTNLM OT - Energy metabolism OT - Fatty liver OT - Lipid metabolism OT - Quamoclit angulata OT - Type 2 diabetes mellitus EDAT- 2022/05/10 06:00 MHDA- 2022/08/17 06:00 CRDT- 2022/05/09 18:14 PHST- 2021/10/26 00:00 [received] PHST- 2022/03/21 00:00 [revised] PHST- 2022/03/22 00:00 [accepted] PHST- 2022/05/10 06:00 [pubmed] PHST- 2022/08/17 06:00 [medline] PHST- 2022/05/09 18:14 [entrez] AID - S0271-5317(22)00028-8 [pii] AID - 10.1016/j.nutres.2022.03.012 [doi] PST - ppublish SO - Nutr Res. 2022 Aug;104:10-19. doi: 10.1016/j.nutres.2022.03.012. Epub 2022 Mar 27.